1. Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 2008; 165: 459–467.
2. Zalsman G . Genetics of suicidal behavior in children and adolescents. In: Dwivedi Y (ed). The Neurobiological Basis of Suicide. Boca Raton, FL, USA: CRC Press, 2012.
3. Center for Disease Control, Division of Violence Prevention. Suicide. 2012 Available at
http://www.cdc.gov/violenceprevention/pdf/suicide-datasheet-a.PDF
(accessed on 10 December 2012).
4. Reeves RR, Ladner ME . Antidepressant-induced suicidality: implications for clinical practice. South Med J 2009; 102: 713–718.
5. FDA. FDA launches a multi-pronged strategy to strengthen safeguards for children treated with antidepressant medications. Available at
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108363.htm
(accessed on 15 October 2004).